Trials / Completed
CompletedNCT06404827
The Effect of Hippotherapy Simulator in Children with Spastic Cerebral Palsy
Investıgatıon of the Effect of Hıppotherapy Sımulator on Lower Extremıty Selectıve Motor Control, Balance and Trunk Control in Chıldren Wıth Spastıc Cerebral Palsy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Hasan Kalyoncu University · Academic / Other
- Sex
- All
- Age
- 5 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The horseback riding simulator (HRS) is a dynamic robotic device that mimics the movement of a horse for hippotherapy purposes. HRS aims to improve the patient's balance, adaptation and provide postural adjustment by mimicking the rhythmic movements of the horse. This study aims to research the potential benefits of the horseback riding simulator on the lower extremity selective motor control, balance and trunk control in children with Cerebral palsy.
Detailed description
Between the dates of the study, children with Cerebral palsy (CP) who meet the inclusion criteria will be allocated into two groups (intervention group, control group) by randomiZation method. Intervention group: horseback riding simulator (HRS) will be applied in addition to routine Physiotherapy and Rehabilitation. This group will receive 20 minutes of routine physiotherapy training and 20 minutes of HRS application in addition to 2 sessions per week for 8 weeks. Control group: Routine physiotherapy training will be applied within a specific programme for 40 minutes in 2 sessions per week for 8 weeks. All the assessments will be performed before and after the training in the 8-week groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Horseback riding simulator | Horseback riding simulator (HRS) will be applied in addition to routine Physiotherapy and Rehabilitation. |
| OTHER | Routine Physiotherapy and Rehabilitation | Routine Physiotherapy and Rehabilitation within a spesific programme |
Timeline
- Start date
- 2024-02-20
- Primary completion
- 2024-11-20
- Completion
- 2024-11-21
- First posted
- 2024-05-08
- Last updated
- 2025-01-15
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06404827. Inclusion in this directory is not an endorsement.